CMS Open Payments · Program Year 2024
STRATA Skin Sciences, Inc.
STRATA Skin Sciences, Inc. reported $89,288.68 across General Payments, Research, and Ownership to 2,465 physicians and teaching hospitals across 2,465 transactions.
- $89.3K Below-median payer
- All-tracks total
- 2,465 Top quartile volume
- Transactions
- 2,465 Top quartile reach
- Recipients
- −$36.6K
- General Payments vs PY2023
STRATA Skin Sciences, Inc. reported $89,288.68 across all CMS Open Payments tracks (General + Research + Ownership) to 2,465 physicians and teaching hospitals in Program Year 2024 - ranking #1213 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $89,288.68, averaging $36.22 per recipient.
How STRATA Skin Sciences, Inc.'s $89.3K all-tracks total breaks down
STRATA Skin Sciences, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
23/100
Total payments
F
11/100
Transaction volume
F
28/100
Physician reach
F
29/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer strata-skin-sciences-inc STRATA Skin Sciences, Inc.
$89.3K · #1213/1,925 · 0.0% industry · PY2024
- TOT $89.3K
- RANK #1213
- SHARE 0.0%
- TXN 2,465
- RCP 2,465
- CAT 2
- GEN $89.3K
- ΔGEN −$36.6K
- TOP1 28.0%
- PY 2024
Volume peers
Nearest volume peer: CashFlow Solutions, LLC ($89.2K)
STRATA Skin Sciences, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
STRATA Skin Sciences, Inc.'s CMS-reported General Payments decreased by $36.6K (−29.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: STRATA SKIN SCIENCES, INC.PY2023: STRATA SKIN SCIENCES, INC.PY2024: STRATA Skin Sciences, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $125,889.21
- PY2024
- $89,288.68
What the Data Shows for STRATA Skin Sciences, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For STRATA Skin Sciences, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 2 general-payment categories charted below, "Food and Beverage" is the largest at $48.8K across 2,452 transactions, 54.6% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
STRATA Skin Sciences, Inc. made 2 types of general payments. "Food and Beverage" is the largest category at $48.8K, 54.6% of General Payments.
How STRATA Skin Sciences, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $48.8K | 2,452 | 54.6% |
| Consulting Fee | $40.5K | 13 | 45.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $42,222.87 (47.3%) of $89,288.68 in this company's General Payments records across 1,040 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for STRATA Skin Sciences, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Daniel M Siegel
$25,000.00 across 5 reported transactions
- 2
Michael R Nazareth
$9,779.79 across 20 reported transactions
- 3
Michael H Gold
$3,137.15 across 26 reported transactions
- 4
Girish S Munavalli
$2,800.00 across 2 reported transactions
- 5
Michael T Lin
$1,505.93 across 11 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
STRATA Skin Sciences, Inc.'s spend rank (#1213 of 1,925, bottom 37% by spend) and concentration rank (#1,051 of 1,838, bottom 43% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Occlutech US LLC : $1.2M total payments, HHI 961
- Cytyc Surgical Products, LLC : $12.4K total payments, HHI 961
- BioXcel Therapeutics, Inc. : $116.0K total payments, HHI 958
- Spinefrontier, Inc. : $26.7K total payments, HHI 958
- PARI Respiratory Equipment, Inc. : $262.70 total payments, HHI 954
- Rayner Intraocular Lenses Limited : $262.7K total payments, HHI 950
- STRATA Skin Sciences, Inc. (this company) : $89.3K total payments, HHI 940
- Neptune Medical Inc. : $119.4K total payments, HHI 936
- Spirair, Inc. : $58.8K total payments, HHI 936
- Neoss, Inc. : $107.6K total payments, HHI 934
- Acist Medical Systems, Inc. : $163.3K total payments, HHI 931
- USA Angelalign Technology Corp : $100.0K total payments, HHI 930
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as STRATA Skin Sciences, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about STRATA Skin Sciences, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with STRATA Skin Sciences, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Synaptic Medical Corporation
Thommen Medical USA, LLC
Pinnacle, Inc
Change Healthcare Technologies, LLC
Valley Contax, Inc.
Put this to use
STRATA Skin Sciences, Inc. ranks #1213 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just STRATA Skin Sciences, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.